C-Rad AB (publ) (STO:CRAD.B)

Market Cap	1.01B
Revenue (ttm)	469.80M
Net Income (ttm)	32.25M
Shares Out	33.58M
EPS (ttm)	0.96
PE Ratio	31.51
Forward PE	17.81
Dividend	n/a
Ex-Dividend Date	n/a

Volume	12,706
Average Volume	32,715
Open	30.10
Previous Close	29.55
Day's Range	29.80 - 30.20
52-Week Range	26.05 - 49.95
Beta	0.91
RSI	52.09
Earnings Date	May 7, 2025

About C-Rad AB

C-Rad AB (publ) develops, manufactures, and sells products and systems with applications in radiotherapy for the treatment of cancer in Europe, the Middle East, Africa, the Americas, and the Asia Pacific. The company’s products include Sentinel 4DCT, a laser-based optical surface scanning system; Catalyst+ HD, a patient positioning, intra-fraction motion management, and respiratory gating solution for conventional and stereotactic treatment delivery; Catalyst+, a solution for patient set up and intra-fraction breath hold reproducibility; Cataly...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2004
• Employees: 99
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: CRAD.B

Financial Performance

In 2024, C-Rad AB's revenue was 469.00 million, an increase of 10.45% compared to the previous year's 424.62 million. Earnings were 56.45 million, an increase of 58.88%.